Anti-infective monoclonal antibody (Aridis Pharmaceuticals)

N/A

Report date: 2022/12/31 19:21:25

Base Information

Drug NameAnti-infective monoclonal antibody (Aridis Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsCystic FibrosisPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKenta Biotech
China Registration ClassN/A

Develop Information

Active CompaniesKenta BiotechAridis Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCystic FibrosisPneumonia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A